XML 33 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Financial Instruments
 12 Months Ended
Apr. 30, 2024
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
The following tables show the Company’s financial instruments and balance sheet classification as of April 30, 2024 and 2023:
April 30, 2024
Fair Value Measurement Balance Sheet Classification
CostUnrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Marketable
Securities,
Current		Marketable
Securities,
Non-current
Other Accrued Liabilities
(in thousands)
Changes in Fair Value Recorded in
Other Comprehensive Loss
Level 2:
Commercial paper$16,873 $1 $(19)$16,855 $3,932 $12,923 $— $— 
Corporate notes/bonds17,322 3 (27)17,298 — 10,050 7,248 — 
U.S. Treasury and Agency Securities4,355 — (9)4,346 — 2,441 1,905 — 
Total debt investments$38,550 $4 $(55)$38,499 $3,932 $25,414 $9,153 $— 
Changes in Fair Value Recorded in
Net Income
Level 1:
Mutual funds (1)
$219,856 $— $17,328 $202,528 $— 
Total equity investments$219,856 $— $17,328 $202,528 $— 
Cash$790,938 $790,938 $— $— $— 
Money market funds146,135 146,135 — — — 
Level 2:     
Foreign currency forward contracts(427)— — — (427)
Total$1,195,001 $941,005 $42,742 $211,681 $(427)
April 30, 2023
Fair Value Measurement Balance Sheet Classification
CostUnrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Marketable
Securities,
Current		Marketable
Securities,
Non-current
Income Taxes & Other
Receivables
(in thousands)
Changes in Fair Value Recorded in
Other Comprehensive Loss
Level 2:
Commercial paper$11,751 $— $(30)$11,721 $— $11,721 $— $— 
Corporate notes/bonds24,754 — (355)24,399 — 21,492 2,907 — 
Total debt investments$36,505 $— $(385)$36,120 $— $33,213 $2,907 $— 
Changes in Fair Value Recorded in
Net Income
Level 1:
Mutual funds (1)
$187,757 $— $11,624 $176,133 $— 
Total equity investments$187,757 $— $11,624 $176,133 $— 
Cash$696,180 $696,180 $— $— $— 
Money market funds147,844 147,844 — — — 
Level 2:
Foreign currency forward contracts2,133 — — — 2,133 
Total$1,070,034 $844,024 $44,837 $179,040 $2,133 
_______________________________
(1)These investments are held in trust for settlement of the Company’s vested obligations of $198.6 million and $172.2 million as of April 30, 2024 and 2023, respectively, under the ECAP (see Note 6 — Deferred Compensation and Retirement Plans). Unvested obligations under the deferred compensation plans totaled $22.4 million and $21.9 million as of April 30, 2024 and 2023, respectively. During fiscal 2024 and 2023, the fair value of the investments increased; therefore, the Company recognized income of $29.8 million and $2.9 million, respectively, which was recorded in other income (loss), net. During fiscal 2022, the fair value of the investments decreased; therefore, the Company recognized a loss of $12.0 million which was recorded in other income (loss), net.
Investments in marketable securities classified as available-for-sale securities are made based on the Company’s investment policy, which restricts the types of investments that can be made. As of April 30, 2024 and 2023 marketable securities classified as available-for-sale consisted of commercial paper and corporate notes/bonds, and also included U.S. Treasury and Agency securities as of April 30, 2024, for which market prices for similar assets are readily available. Investments that have an original maturity of 90 days or less and are considered highly liquid investments are classified as cash equivalents. As of April 30, 2024, available-for-sale marketable securities had remaining maturities ranging from less than 1 month to 23 months. During fiscal 2024, 2023 and 2022, there were $38.1 million, $58.6 million and $79.3 million in sales/maturities of available-for-sale marketable securities, respectively. Investments in marketable securities that are held in trust for settlement of the Company’s vested obligations under the ECAP are equity securities and are based upon the investment selections the employee elects from a pre-determined set of securities in the ECAP and the Company invests in equity securities to mirror these elections. As of April 30, 2024 and 2023, the Company’s investments in equity securities consisted of mutual funds for which market prices are readily available. Unrealized gains that relate to equity securities still held as of April 30, 2024 was $25.1 million, while unrealized losses that relate to equity securities held as of April 30, 2023, and 2022 were $3.8 million and $27.3 million, respectively.
Foreign Currency Forward Contracts Not Designated as Hedges
The fair value of derivatives not designated as hedge instruments are as follows:
April 30,
20242023
(in thousands)
Derivative assets:
Foreign currency forward contracts$979 $2,813 
Derivative liabilities:
Foreign currency forward contracts$1,406 $680 
As of April 30, 2024, the total notional amounts of the forward contracts purchased and sold were $82.9 million and $34.0 million, respectively. As of April 30, 2023, the total notional amounts of the forward contracts purchased and sold were $112.7 million and $41.1 million, respectively. The Company recognizes forward contracts as a net asset or net liability on the consolidated balance sheets as such contracts are covered by master netting agreements. During fiscal 2024 and 2023, the Company incurred gains of $0.6 million and $2.1 million, respectively, related to forward contracts which is recorded in general and administrative expenses in the accompanying consolidated statements of income. During fiscal 2022, the Company incurred losses of $0.2 million, related to forward contracts which is recorded in general and administrative expenses in the accompanying consolidated statements of income. These foreign currency gains/losses offset foreign currency losses/gains that result from transactions denominated in a currency other than the Company’s functional currency. The cash flows related to foreign currency forward contracts are included in cash flows from operating activities.